No Data
Baolingbao Biology (002286.SZ): The enterprises controlled by the actual controller plan to postpone the implementation of the Shareholding plan.
On March 21, Gelonghui reported that Baolingbao Biology (002286.SZ) announced that Mr. Dai Sicong, the actual controller of Songjing Investment, is a permanent resident of Hong Kong. Due to his financial arrangements and fund transfers, it is expected that this shareholding plan will not be completed within the original timeframe. In consideration of confidence in the company's future development and to protect the interests of the shareholders, Songjing Investment intends to extend this shareholding plan by 12 months until April 7, 2026, while all other contents of the original shareholding plan remain unchanged.
Baolingbao Biology CFO Steps Down; Successor Named
Baolingbao Biology (002286.SZ) has appointed Zhou Yu as the Chief Financial Officer.
Baolingbao Biology (002286.SZ) announced that the company's Board of Directors received a report from the company's deputy general manager on February 12, 2025...
EU Places Lowest Anti-Dumping Duty Rate on Baolingbao Biology
Bowling Bao: 2024 Annual Results Forecast
Baolingbao Biology (002286.SZ): Songjing Investment has cumulatively increased its shareholding by 0.325%.
On January 7, Gelonghui reported that Baolingbao Biology (002286.SZ) announced that as of the date of this announcement, the implementation period of the current Shareholding plan has passed the halfway mark. Songjing Investment has cumulatively increased its holdings of the company's Stocks by 1,201,600 shares, accounting for 0.3250% of the company's total share capital. This Shareholding plan has not yet been completed, and Songjing Investment will continue to increase its holdings of the company's shares in accordance with the relevant Shareholding plan within the implementation period. As of the date of this announcement, Songjing Investment holds 18,581,737 shares of the company, accounting for 5.0253% of the company's total share capital.
Pinning Down Baolingbao Biology Co.,Ltd.'s (SZSE:002286) P/E Is Difficult Right Now
